Global prebiotics for infant formula market is projected to register a substantial CAGR in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:
By Type (Human Milk Oligosaccharides (HMOS), Galactooligosaccharides (GOS), Fructooligosaccharides (FOS), Mannan-Oligosaccharides (MOS), Polydextrose (PDX), Lactulose (LOS), Inulin), Source (Bacteria, Algae, Fungi, Plants & Vegetables), Grade (Inorganic, Organic), Form (Powder, Liquid), Product Type (Standard Formula, Toddler Formula, Follow Up Formula, Special Formula), Infant Age (0-6 Months, 6-12 Months, 1-3 Years), By Geography (North America, Asia-Pacific, Europe, South America, Middle East & Africa), Market Trends and Forecast to 2027
Some of the major factors contributing to the growth of the global prebiotics for infant formula market:

? Rising Number from Preterm/Premature Babies
? Increased Research Initiative for New Product Development

Market Players:
The key market players for global prebiotics for infant formula market are listed below:

- Jennewein Biotechnologie GmbH
- zuChem Inc
- Biosynth Carbosynth
- ElicitylSA
- Dextra Laboratories Limited
- Glycom A/S
- Tereos
- Ingredion Incorporated
- Royal FrieslandCampina N.V
- Sudzucker AG
- Cargill, Incorporated
- Fonterra Co-operative Group
- Royal Cosun
- COSUCRA
- New Francisco (Yunfu City) Biotechnology Corporation Limited
- Dana Dairy Group
- Glycosyn LLC
- DuPont